The aim of the study was to evaluate the effectiveness of breathing exercises given by telemedicine in post-Covid-19 dyspneic individuals. Individuals in the intervention group ( n: 26) were asked to perform breathing exercise three times a day for 5 weeks (one session performed via telemedicine each week). Individuals in the control group ( n: 26) were given a brochure explaining the exercises. The St George’s Respiratory Questionnaire, Pulmonary function tests, and six-minute-walk-tests were administered to all individuals at the beginning and end of the study. The posttest FEV1, FVC, MVV values were significantly higher than the pretest values in the intervention group (p2 < .001) whereas no significant differences were found in the control group. Six-minute-walk-distance increased by 54.27 m in the intervention group and 4.69 m in the control group. With breathing exercise training applied through telemedicine, improvements were observed in the pulmonary functions, quality of life, and exercise capacities of dyspneic post-Covid-19 individuals.
1274 seudochylothorax, which is also termed as chyliform pleural effusion or cholesterol pleural effusion is an entity that develops as a result of increase in the amount of cholesterol in fluids with long-standing exudative characteristics and resembles to chylothorax.1 It is generally observed in pleural effusions lasting more than five years.2 Up to 1999, a total of 29 publications and 172 case reports regarding pseudochylothorax which is a rare form of pleural effusions have been cited in the literature. 3 The most common causes of pseudochylothorax are tuberculous pleurisy, chroPseudochylothorax Secondary to Rheumatoid Arthritis: Case Report A AB BS S T TR RA AC CT T A 61-year-old women was referred to our clinic because of bilateral pleural fluid in her chest X-ray. Her history revealed that swelling and stiffness in her joints was diagnosed as rheumatoid arthritis five years ago. On admission, the patient had no complaints, appeared well, and her vital signs were normal. Lung examination revealed that breath sounds were diminished in both lung bases. We did thoracentesis which yielded a milky-odorless fluid. Biochemical characteristics of the fluid was consistent with exuda; trigliseride: 20 mg/dl, cholesterol: 286 mg/dl. Direct smear and culture for acid fast bacilli were negative. Thoracic computerized tomography scans revealed bilateral pleural fluid, volume loss of the left lung with ipsilateral shifting of mediastinum. According to clinicoradiological and laboratory findings, we concluded that pseudochylothorax was the result of chronic rheumatoid pleurisy. Since pseudochylothorax is an uncommon entity detected during the analyses of pleural fluids, we intended to present our rarely seen case with pseudochylothorax.K Ke ey y W Wo or rd ds s: : Arthritis, rheumatoid; pleurisy; chylothorax; cholesterol; triglycerides Ö ÖZ ZE ET T Altmış bir yaşında bayan hasta, akciğer grafisinde bilateral plevral efüzyon nedeniyle kliniğimize yönlendirilmiş. Özgeçmişinde; beş yıl önce eklemlerinde şişlik-tutukluk şikayeti olmuş, romatoid artrit tanısı konulmuş. Kliniğimize başvurusunda yakınması yoktu, fizik muayenesinde genel durumu iyi, vital bulguları stabildi. Bilateral akciğer bazallerinde solunum sesleri hafif azalmıştı. Torasentezle alınan mayi sütsü görünümde, kokusuz, biyokimyasal incelemesi eksüda karakterinde, trigliserid: 20 mg/dl, kolesterol: 286 mg/dl idi. Sıvının asit rezistan bakteri teksif ve kültür incelemesi negatifti. Bilgisayarlı toraks tomografisinde bilateral plevral efüzyon, sol akciğerde volüm kaybı, kalp ve mediastende sola deviasyon tespit edildi. Mevcut klinik-laboratuvar ve radyolojik bulgularla kronik romatoid plöreziye bağlı psödoşilotoraks kabul edildi. Psödoşilotoraks plevra sıvıları içinde nadir görüldüğünden olgu sunulmuştur. Handan İNÖNÜ, MD,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.